Skip to main content

Pay Bill Portals

Our Tests
Our Services
- - Oncology
    - - SERVICES
        
        NateraCore Services
        
        Pharma Partnership
        
        Real-World Data
        
        EMR Integration
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
        
        Contact Us
    - - FOR CLINICIANS
        
        Schedule Session With Client Services
        
        Oncology Portal
        
        Order a Test Kit
        
        Contact Us
  - Organ Health
    - - SERVICES
        
        NateraCore Services
        
        ProReach
        
        EMR Integration
        
        Pharma Services
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Order a Renasight Kit
        
        Contact Us
        
        Pricing and Billing Information
    - - FOR CLINCIANS
        
        Organ Health Portal
        
        Order a Renasight Kit
        
        Contact Us
  - Women’s Health
    - - SERVICES
        
        NateraCore Services
        
        Constellation
        
        EMR Integration
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Pricing and Billing Information
        
        Women’s Health Portal
        
        Contact Us
    - - FOR CLINICIANS
        
        Order Tests and Track Status on NateraConnect
        
        View Patient Results on NateraConnect
        
        Contact Us
Patient Resources
- - Oncology
    - - LEARN
        
        Signatera
        
        Altera
        
        Empower
        
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
    - - CONNECT
        
        Contact Us
  - Organ Health
    - - LEARN
        
        Prospera
        
        Renasight
        
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule a Genetic Information Session
        
        Pricing and Billing Information
    - - CONNECT
        
        Contact Us
  - Women’s Health
    - - LEARN
        
        Horizon
        
        Panorama
        
        Empower
        
        Vistara
        
        Anora
        
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Blood Draw (Existing Patients – USA)
        
        Schedule Blood Draw (Existing Patients – Canada)
        
        Pricing and Billing Information
        
        Women’s Health Portal
    - - CONNECT
        
        Contact Us
Clinical Resources
- - Oncology
    - - CLINICAL RESOURCES
        
        Signatera
        
        Signatera Publications
        
        Altera
        
        Empower
        
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        Signatera Research Pipeline
        
        Natera Sponsored Trials
    - - CONNECT
        
        Oncology Portal
        
        Contact Us
  - Organ Health
    - - CLINICAL RESOURCES
        
        Organ Health Publications
        
        Prospera
        
        Renasight
        
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        ProActive Study
        
        PEDAL Study
        
        Trifecta Study
        
        MOTR Study
    - - CONNECT
        
        Organ Health Portal
        
        Contact Us
  - Women’s Health
    - - CLINICAL RESOURCES
        
        Women’s Health Publications
        
        Horizon
        
        Panorama
        
        Empower
        
        Vistara
        
        Anora
        
        Natera Academy Provider Education Hub
        
        View All Clinician Resources
    - - RESEARCH STUDIES
    - - CONNECT
        
        Contact Us
Company
Search for:
Pay Bill

Portals
Search for:

Natera, Inc.

- Altera
- Anora
- Empower
- Horizon
- Panorama
- Prospera
- Renasight
- Signatera
- Spectrum
- Vistara
- Blog
- Videos
- Brochure
- Whitepaper
- Manual
- Poster
- Report
- Study
- Webinars
- Natera Academy

Recent Searches

Home
Signatera
Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors, a Feasibility Study

Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors, a Feasibility Study

Reason E. H. et al; Ann Surg Oncol 2025

Previous Resource

Peri-operative atezolizumab in early-stage triple-negative breast cancer: final results and ctDNA analyses from the randomized phase 3 IMpas

Mittendorf E. A. et al; Nature Medicine 2025
Next Resource

Detection and Monitoring of Breast Cancer Local Recurrence Via Circulating Tumor DNA Minimal Residual Disease Assay

Prasath V, et al; JCO Precision Oncology 2025

Related Content

Alteration of the Tumor Microenvironment With Intratumoral Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer A Nonrandomized Clinic

Han, H.S. et al; JAMA Oncology 2025

Read More
Adjuvant endocrine therapy with cyclindependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/ HER2– breast canc

Spring L. M. et al; npj Breast Cancer 2025

Read More
Personalized Circulating Tumor DNA Testing for Detection of Progression and Treatment Response Monitoring in Patients With Metastatic Invasi

Foldi J; JCO Precision Oncology 2025

Read More
Peri-operative atezolizumab in early-stage triple-negative breast cancer: final results and ctDNA analyses from the randomized phase 3 IMpas

Mittendorf E. A. et al; Nature Medicine 2025

Read More
Detection and Monitoring of Breast Cancer Local Recurrence Via Circulating Tumor DNA Minimal Residual Disease Assay

Prasath V, et al; JCO Precision Oncology 2025

Read More
Circulating tumor DNA refines risk stratification of neoadjuvant therapyresistant breast tumors

Magbanua M. J. et al; Nature Communications 2025

Read More
Exploring the utility of ctDNA testing in high-risk breast cancer patients in a community setting: case series

Wong K, et al; Ther Adv Med Oncol 2025

Read More
Meet Jon, Muscle-Invasive Bladder Cancer (MIBC) Survivor and Signatera Patient

Read Article
1 day ago
Dr. Barry Rosen - Nothing Else Compares

Dr. Barry Rosen answers the question to "Why did you start incorporating MRD in your practice?" Dr. Rosen discusses why he incorporated MRD testing into their patient care algorithm. They note that tr

Watch Video
9 days ago
PARPi Study Publication Summary

Read More
11 days ago
Validation of a methylation-based, tissue-free MRD assay in colorectal cancer patients from the GALAXY study

Nakamura Y. Reiter J.G. Natarajan P. et al. npj Precis. Onc. 2026

Read More
Meet Amanda, Colorectal Cancer Survivor and Signatera Patient

Read Article
11 days ago
Meet Amanda, Colorectal Cancer Survivor and Signatera Patient

Amanda shares her powerful and unexpected journey. A routine genetic screening during her pregnancy led to a Stage IV colon cancer diagnosis. She underwent chemo while pregnant, had surgery after her

Watch Video
How to Prepare for Your Next MRD Test: Practical Tips and FAQs

Read Article
Looking Back at 2025: How Natera Supported Cancer Survivors

Read Article
about 2 months ago
Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib

Zhang et al. JAMA Oncology 2025

Read More
about 2 months ago
Integrating ctDNA and utDNA Across the Bladder Cancer Continuum

Watch Video
about 2 months ago
Inform timing on adding CTLA-4 to PD-1 monotherapy

Read More
about 2 months ago
Circulating tumor DNA refines risk stratification of neoadjuvant therapy- resistant breast tumors

Mark Jesus M. Magbanua, et al. Nature Communications 2025

Read More
From Detection to Direction: Signatera MRD testing and its impact in CRC

Watch Video

Return to Resource Library

© Natera, Inc.

Our Tests
Our Services
Patient Resources
Clinical Resources
- Resource Library
- Provider Portals
Company
Contact

Natera Licenses
IT Security Compliance
Natera Notice of Data Collection for California Residents
HIPAA Notice of Privacy Practices
Privacy Policy
Terms of Use
Sitemap

The tests described have been developed and their performance characteristics determined by the CLIA-certified laboratory performing the test. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2026 Natera, Inc. All Rights Reserved.